Verona Pharma PLC ADR (VRNA) Insider Trading
- $378,874.24
- $106,067,573.68
- May 3, 2024
- David Zaccardelli
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 3, 2024 | Insider | 36,248 | $1.96 | Sell | $71,046.08 | |
Nov. 20, 2023 | Director | 33,736 | $1.84 | Buy | $62,074.24 | |
Nov. 6, 2023 | Director | 160,000 | $1.98 | Buy | $316,800.00 | |
Nov. 3, 2023 | Insider | 58,752 | $1.92 | Sell | $112,803.84 | |
Aug. 7, 2023 | Insider | 1,600 | $2.47 | Sell | $3,952.00 | |
Aug. 7, 2023 | General Counsel | 1,512 | $2.47 | Sell | $3,734.64 | |
Aug. 7, 2023 | CEO | 8,616 | $2.47 | Sell | $21,281.52 | |
Aug. 4, 2023 | CEO | 150,000 | $2.50 | Sell | $375,000.00 | |
Aug. 3, 2023 | Insider | 50,600 | $2.55 | Sell | $129,030.00 | |
Aug. 3, 2023 | CFO | 117,272 | $2.54 | Sell | $297,870.88 | |
Aug. 3, 2023 | General Counsel | 20,608 | $2.54 | Sell | $52,344.32 | |
Aug. 2, 2023 | CEO | 73,704 | $2.59 | Sell | $190,893.36 | |
Aug. 1, 2023 | CFO | 105,944 | $2.68 | Sell | $283,929.92 | |
Aug. 1, 2023 | General Counsel | 18,608 | $2.68 | Sell | $49,869.44 | |
Aug. 1, 2023 | Insider | 19,736 | $2.68 | Sell | $52,892.48 | |
May 15, 2023 | Director | 359,713 | $20.08 | Sell | $7,223,037.04 | |
May 11, 2023 | Director | 80,000 | $22.26 | Sell | $1,780,800.00 | |
May 3, 2023 | Insider | 28,752 | $2.65 | Sell | $76,192.80 | |
May 1, 2023 | General Counsel | 80,376 | $2.58 | Sell | $207,370.08 | |
May 1, 2023 | CFO | 455,528 | $2.58 | Sell | $1,175,262.24 | |
May 1, 2023 | Insider | 77,424 | $2.58 | Sell | $199,753.92 | |
May 1, 2023 | CEO | 455,536 | $2.58 | Sell | $1,175,282.88 | |
Feb. 1, 2023 | CEO | 432,928 | $2.56 | Sell | $1,108,295.68 | |
Feb. 1, 2023 | CFO | 413,168 | $2.56 | Sell | $1,057,710.08 | |
Feb. 1, 2023 | Insider | 89,960 | $2.56 | Sell | $230,297.60 | |
Feb. 1, 2023 | General Counsel | 152,000 | $2.59 | Sell | $393,680.00 | |
Dec. 22, 2022 | Director | 3,969,496 | $21.77 | Sell | $86,415,927.92 | |
Dec. 22, 2022 | General Counsel | 240,000 | $2.69 | Sell | $645,600.00 | |
Dec. 20, 2022 | CEO | 600,000 | $2.12 | Sell | $1,272,000.00 | |
Aug. 9, 2022 | CEO | 600,000 | $1.75 | Sell | $1,050,000.00 | |
Aug. 2, 2022 | Insider | 28,752 | $0.70 | Sell | $20,126.40 | |
Aug. 1, 2022 | CEO | 32,904 | $0.70 | Sell | $23,032.80 | |
Aug. 1, 2022 | CFO | 13,168 | $0.70 | Sell | $9,217.60 | |
May 3, 2022 | CEO | 32,904 | $0.50 | Sell | $16,452.00 | |
May 3, 2022 | CFO | 12,512 | $0.50 | Sell | $6,256.00 | |
May 3, 2022 | Insider | 28,752 | $0.49 | Sell | $14,088.48 | |
April 11, 2022 | Insider | 59,720 | $0.54 | Sell | $32,248.80 | |
April 8, 2022 | Insider | 112,800 | $0.59 | Sell | $66,552.00 | |
Feb. 3, 2022 | CEO | 52,056 | $0.73 | Sell | $38,000.88 | |
Feb. 2, 2022 | CFO | 10,416 | $0.76 | Sell | $7,916.16 | |
Feb. 1, 2022 | Director | 11,664 | $0.78 | Sell | $9,097.92 | |
Nov. 2, 2021 | Director | 11,672 | $0.66 | Sell | $7,703.52 | |
Nov. 2, 2021 | CFO | 10,416 | $0.65 | Sell | $6,770.40 | |
Nov. 2, 2021 | CEO | 52,056 | $0.64 | Sell | $33,315.84 | |
Aug. 3, 2021 | CEO | 16,000 | $0.76 | Sell | $12,160.00 | |
Aug. 2, 2021 | CFO | 10,416 | $0.77 | Sell | $8,020.32 | |
May 4, 2021 | Director | 12,056 | $0.84 | Sell | $10,127.04 | |
March 1, 2021 | CFO | 26,728 | $1.14 | Sell | $30,469.92 | |
March 1, 2021 | CEO | 43,392 | $1.14 | Sell | $49,466.88 | |
Feb. 1, 2021 | Director | 10,800 | $0.99 | Sell | $10,692.00 |
Insiders are both buying and selling Verona Pharma PLC ADR stock.
The insider traders at Verona Pharma PLC ADR are: David Zaccardelli, Kathleen A Rickard, Mark W Hahn, Claire Poll, Orbimed Advisors Llc, Lisa Deschamps, Anders Ullman, Mark W. Hahn, Martin Edwards, and David R Ebsworth
The most active insider trader at Verona Pharma PLC ADR is David Zaccardelli with 13 trades.
Orbimed Advisors Llc has sold the most Verona Pharma PLC ADR stock with a total value of $102,642,802.00.
David R Ebsworth has bought the most Verona Pharma PLC ADR stock with a total value of $633,600.00.
The most recent insider trade for Verona Pharma PLC ADR was on May 3, 2024.
The single biggest insider buy for Verona Pharma PLC ADR was from David R Ebsworth with a total value of $316,800.00 on Nov. 6, 2023.
The single biggest insider sell for Verona Pharma PLC ADR was from Orbimed Advisors Llc with a total value of $86,415,927.92 on Dec. 22, 2022.